These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34521850)

  • 1. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
    Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M
    Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of regulatory T cells that modulate vascular inflammation.
    Franco A; Touma R; Song Y; Shimizu C; Tremoulet AH; Kanegaye JT; Burns JC
    Autoimmunity; 2014 Mar; 47(2):95-104. PubMed ID: 24490882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of miR-27a promotes monocyte-mediated inflammatory responses in Kawasaki disease by inhibiting function of B10 cells.
    Luo Y; Yang J; Zhang C; Jin Y; Pan H; Liu L; Gong Y; Xia Y; Wang G; Zhang J; Li C; Li Q
    J Leukoc Biol; 2020 Jan; 107(1):133-144. PubMed ID: 31583766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
    Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
    Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
    [No Abstract]   [Full Text] [Related]  

  • 6. Clonal expansion of CD8+ T cells in Kawasaki disease.
    Choi IH; Chwae YJ; Shim WS; Kim DS; Kwon DH; Kim JD; Kim SJ
    J Immunol; 1997 Jul; 159(1):481-6. PubMed ID: 9200489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
    Ehara H; Kiyohara K; Izumisawa Y; Ito T
    Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.
    Burns JC; Song Y; Bujold M; Shimizu C; Kanegaye JT; Tremoulet AH; Franco A
    Clin Exp Immunol; 2013 Dec; 174(3):337-44. PubMed ID: 23901839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
    Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
    Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
    Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M
    Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
    McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
    Front Immunol; 2021; 12():660506. PubMed ID: 34093549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles and Kawasaki disease: a marker of vascular damage?
    Guiducci S; Ricci L; Romano E; Ceccarelli C; Distler JH; Miniati I; Calabri GB; Distler O; Matucci Cerinic M; Falcini F
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S121-5. PubMed ID: 21385556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single cell RNA-seq resolution revealed CCR1
    Liu X; Luo T; Fan Z; Li J; Zhang Y; Lu G; Lv M; Lin S; Cai Z; Zhang J; Zhou K; Guo J; Hua Y; Zhang Y; Li Y
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166707. PubMed ID: 37001702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atlas of circulating immune cells in Kawasaki disease.
    Xie Z; Huang Y; Li X; Lun Y; Li X; He Y; Wu S; Wang S; Sun J; Zhang J
    Int Immunopharmacol; 2022 Jan; 102():108396. PubMed ID: 34890998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin a suppresses peripheral CD8
    Wu Q; Weng R; Xu Y; Wang L; Huang Y; Yang J
    BMC Immunol; 2021 Feb; 22(1):17. PubMed ID: 33622252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing single-cell RNA sequencing for analyzing the characteristics of PBMC in patients with Kawasaki disease.
    Fan X; Zhou Y; Guo X; Xu M
    BMC Pediatr; 2021 Jun; 21(1):277. PubMed ID: 34126969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease and the T-cell antigen receptor.
    Jason J; Montana E; Donald JF; Seidman M; Inge KL; Campbell R
    Hum Immunol; 1998 Jan; 59(1):29-38. PubMed ID: 9544237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.
    Ni FF; Li CR; Li Q; Xia Y; Wang GB; Yang J
    Clin Exp Immunol; 2014 Nov; 178(2):384-93. PubMed ID: 25039241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.